Project Grant HT94252410487
Award Date 7/1/24
Completion Date 6/30/27
Dollars Obligated $747K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
College Station, TX, USA
Similar Awards
- This Project Grant award of $1,332,764.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding the "Therapeutic Development of NC101 for Promoting Neurological Recovery After Chronic SCI" by Neurocreis, Inc. in College Station, TX. The award, which runs from July 1, 2025 to June 30, 2028, supports advanced biomedical research aimed at developing innovative medical solutions to address critical health challenges for military...
- This Project Grant award of $1,067,612.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), will fund a hybrid implementation-effectiveness trial to evaluate home neuromodulation for neurogenic bladder management in individuals with spinal cord injury. The 3-year award, effective October 1, 2025, will be conducted by the University of Texas Health Science Center at Houston (UTHealth), a comprehensive academic health university...
- The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
- This federal Project Grant award, titled "HOME NEUROMODULATION FOR NEUROGENIC BLADDER MANAGEMENT IN SPINAL CORD INJURY: A HYBRID IMPLEMENTATION-EFFICACY TRIAL," is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $662,742 award will support research conducted by The Methodist Hospital Research Institute in Houston, TX from October 1, 2025 to September 30, 2028. The project aims to develop and evaluate a home-based...
- This federal Project Grant award of $1,868,800.00, provided by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420), supports research to investigate the effect of cardiocentric hemodynamic management on cardiovascular outcomes for individuals with acute cervical spinal cord injury. The award was made to the University of British Columbia's Research Services division, which has a history of conducting advanced biomedical research for federal...
- The Defense Health Agency awarded a $963,110 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "SAFETY OF TRANSCUTANEOUS ELECTRICAL STIMULATION POTENTIATING RECOVERY IN ACUTE SPINAL CORD INJURY SYNDROMES (STEP-RAISE)", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- The University of Florida's Division of Sponsored Research received a $718,988 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 3-year project aims to test a novel oxygen release therapeutic for the preservation of spinal cord tissue resulting from spinal cord injury ischemia. Key products and services to be delivered include: Obtaining IACUC and institutional safety approvals, purchasing equipment and animals,...
- This federal Project Grant award of $3,766,416.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) for the project "EXPANSILE DURAPLASTY FOR TREATMENT OF ACUTE TRAUMATIC SPINAL CORD INJURY". The award period runs from July 1, 2025 to June 30, 2029 and will support advanced biomedical research to develop innovative medical solutions for addressing...
- This federal Project Grant award, worth $2,966,875.00, was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a prospective clinical trial to investigate the optimal timing of surgical decompression for patients with acute spinal cord injuries. The grant recipient, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, will conduct the research at its facility in Torrance, California over a...
- The U.S. Defense Health Agency awarded a $792,500.00 Project Grant to Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University-Of The Commonwealth System Of Higher Educa and doing business as Temple University, for the purpose of "AN EFFECTIVE STRATEGY TO PROMOTE AXON REGENERATION AND FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY". The Project Grant is funded through the U.S. Military Medical Research and Development program (CFDA 12.420),...